Maky Zanganeh, COO at Pharmacyclics, holds 35.74M shares in Summit Therapeutics (Ticker: SMMT), holds 813.23K shares in Pulse Biosciences (Ticker: PLSE), holds 0.00 shares in Pharmacyclics (Ticker: PCYC). Most recently, Maky Zanganeh Bought ― shares of Summit Therapeutics on Oct 03, 2024 for an estimated value of 498.78K.
What is the percentage of profitable transactions made by Maky Zanganeh?
The percentage of profitable transactions made by Maky Zanganeh is 58%.
What is the average return per transaction made by Maky Zanganeh?
The average return per transaction made by Maky Zanganeh is 109.30%.
What stocks does Maky Zanganeh hold?
Maky Zanganeh holds: PCYC, PLSE, SMMT stocks.
What was Maky Zanganeh’s latest transaction?
Maky Zanganeh latest transaction was an Informative Buy of $498.78K.
What was Maky Zanganeh's most profitable transaction?
Maky Zanganeh’s most profitable transaction was an Informative Buy of SMMT stock on December 13, 2023. The return on the trade was 711.90%.
What is Maky Zanganeh's role in Pharmacyclics?
Maky Zanganeh's role in Pharmacyclics is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.